Inactivating mutations in MCT8 in humans cause peripheral thyrotoxicity and severe neurocognitive and motor impairments with hypotonia and hypokinesis as key clinical features, better known as Allan–Herndon–Dudley Syndrome (AHDS) [2,3,4]. The gene discussed is SLC16A2; the disease is Allan-Herndon-Dudley syndrome.